IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4092
Positioning
Market Dominance
Manufacturing
Medical Equipment
$171M
Robert Ball
We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. Our principal executive offices are located in Grand Rapids, MI.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = SI ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$SI SHOULDER INNOVATIONS, INC. | 35 | 42 | 27 | 30 | 5.1x | 3.4x | 36.5% | 30.4% | 76.2% | 3.3% | -36.7% | 57.7% | 0.0% | 20.0x | $171M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
SHOULDER INNOVATIONS, INC. (SI) receives a "Avoid" rating with a composite score of 35.2/100. It ranks #4092 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Robert Ball
Chief Executive Officer
Labor Force
61
42
24
52
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for SI
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Average quality profile
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for SI.
View All RatingsImproving capital utilization rates confirmed
High margin volatility — erratic forensic earnings quality
ROE proxy 36.5% (sector -2.5%)
GM 76% vs sector 43%, OM 3% vs sector 1%
Capital turnover N/A, R&D intensity 12.9%
Rev growth 58%, 2yr history
Interest coverage -98.0x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags SHOULDER INNOVATIONS, INC. with an Avoid rating, assigning a composite score of 35.2/100 and 1 out of 5 stars. Ranked #4092 of 7,333 stocks, SI falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
SI's quality score of 42/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of 36.5% (sector avg: -2.5%), gross margins of 76.2% (sector avg: 42.5%), net margins of -36.7% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
SI registers a value score of just 27/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/E ratio of 5.06x, an EV/EBITDA of 3.44x, a P/B ratio of 1.85x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
SHOULDER INNOVATIONS, INC.'s investment score of 24/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 57.7% vs. a sector average of 5.9% and a return on assets of 30.4% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
SI is currently showing below-average momentum at 30/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 57.7% year-over-year, while a beta of 0.76 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
With a stability score of 52/100, SI exhibits average financial resilience. Key stability metrics include a beta of 0.76 and a debt-to-equity ratio of 20.00x (sector avg: 0.2x). While the balance sheet is not a major concern, the stock is subject to typical market volatility and may experience sharper drawdowns during risk-off episodes.
SHOULDER INNOVATIONS, INC.'s short interest score of 25/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 20.00x), micro-cap liquidity risk. At $171M (micro-cap), SI carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
SHOULDER INNOVATIONS, INC. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4092 of 7,333 overall (44th percentile). Key comparisons include ROE of 36.5% exceeding the -2.5% sector median and operating margins of 3.3% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While SI currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Investment (24) would have the largest impact on the composite score.
EV/EBITDA 70% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1573% BELOW SECTOR MEDIAN
Gross Margin 79% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate SHOULDER INNOVATIONS, INC. (SI) as Avoid with a composite score of 35.2/100 at a current price of $13.20. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in stability (52th percentile) and quality (42th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (24th percentile) and value (27th percentile) tempers our overall conviction. We assign a Narrow Moat rating (54/100), Medium uncertainty, and Standard capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs; sustainability of the current growth rate; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
SHOULDER INNOVATIONS, INC. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 35.2/100 places it at rank #4092 in our full 7,333-stock universe. At $171M in market capitalization, SHOULDER INNOVATIONS, INC. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 58%, though momentum at the 30th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 76% (+33.7pp vs sector) narrow to operating margins of 3% (+2.0pp vs sector) and net margins of -36.7%, yielding a gross-to-net conversion rate of -48%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $13.20, SHOULDER INNOVATIONS, INC. is trading at a premium to fundamental value. Our value factor score of 27/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The premium valuation implies the market is pricing in significant future growth or quality improvements that are not yet fully reflected in current fundamentals.
The stock currently trades at a P/E of 5.1x (a 77% discount to the sector median of 22.3x), EV/EBITDA of 3.4x (discounted to peers), P/B of 1.9x, P/S of 1.5x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Gross margins of 76% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Returns on equity of 36.5% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
Revenue growth of 58% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A conservative balance sheet (20% D/E) provides financial flexibility for acquisitions, buybacks, or weathering economic downturns without dilution.
Return on assets of 30.4% indicates efficient deployment of the full asset base, not just equity capital.
We assign a Medium uncertainty rating to SHOULDER INNOVATIONS, INC.. The stock presents a balanced risk profile: current negative profitability (net margin -36.7%). While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: current negative profitability (net margin -36.7%). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 52th percentile and quality factor at the 42th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 76% provide a buffer against cost pressures; conservative leverage (20% D/E) limits balance sheet risk. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate SHOULDER INNOVATIONS, INC.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 36.5%, and the balance sheet is managed within acceptable parameters (D/E: 20%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; SHOULDER INNOVATIONS, INC. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. Absent a dividend, the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, SHOULDER INNOVATIONS, INC. receives a Avoid rating with a composite score of 35.2/100 (rank #4092 of 7,333). Our quantitative framework assigns a Narrow Moat (54/100, trend: stable), Medium uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 35/100.
Our analysis does not support a constructive view on SHOULDER INNOVATIONS, INC. at this time. The combination of the current quantitative profile, medium uncertainty, and standard capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign SHOULDER INNOVATIONS, INC. a Narrow Moat rating with a composite moat score of 54/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that SHOULDER INNOVATIONS, INC. can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being economic value creation at 17.5/20.
The strongest moat sources are economic value creation (17.5/20) and margin superiority (14/20). ROE proxy 36.5% (sector -2.5%). GM 76% vs sector 43%, OM 3% vs sector 1%. These pillars form the core of SHOULDER INNOVATIONS, INC.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (4.5/20) and financial resilience (8.8/20). Capital turnover N/A, R&D intensity 12.9%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect SHOULDER INNOVATIONS, INC.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 76% providing a solid profitability foundation, robust top-line growth of 58% expanding the revenue base, returns on equity of 36.5% driving shareholder value creation. The margin cascade from 76% gross to 3% operating to -36.7% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 42th percentile.
The margin profile shows gross margins of 76%, operating margins of 3%, net margins of -36.7%. Return metrics include ROE of 36.5% and ROA of 30.4%. Relative to the Manufacturing sector, gross margins are 33.7 percentage points above the sector median of 43%, and ROE of 36.5% compares to a sector median of -2.5%.
The balance sheet reflects a conservatively managed balance sheet with D/E of 20%, revenue growth of 58%. The sector median D/E is 0%, putting SHOULDER INNOVATIONS, INC. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
The Avoid rating (composite 35.2/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Thin net margins of -36.7% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Weak momentum (30th percentile) suggests institutional selling pressure and unfavorable technical dynamics that may persist.
Above 50MA
37.18%
Net New Highs
+51081

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. National CineMedia, Inc. (NASDAQ: NCMI) climbed 81% to $0.2409 after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment. IMAC Holdings, Inc. (NASDAQ: BACK) gained 71% to $0.2144. IMAC Holdings and Brain Scientific recently announced a strategic merger to create a synergistic end-to-end neurological solution. WW International, Inc. (NASDAQ: WW) shares jumped 48.9% to $6.14 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $3.8 to $13. ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 47.4% to $2.44 after the company announced it partnered with Google Cloud to disrupt phishing attacks and malicious URLs. Clearmind Medicine Inc. (NASDAQ: CMND) gained 35.4% to $0.5818 after jumping more than 10% on Monday. Silvergate Capital Corporation (NYSE: SI) surged 33% to $1.85. Apollomics, Inc. (NASDAQ: APLM) jumped 30.5% to $10.62. Brookdale Senior Living Inc. (NYSE: BKD) shares gained 23.8% to $3.6899 after the company reported favorable updates to its Q1 financial expectations based upon preliminary, unaudited results. VBI Vaccines Inc. (NASDAQ: VBIV) jumped 23.8% to $0.1696. Nogin, Inc. (NASDAQ: NOGN) gained 22.6% to $2.17 following insider buying. BTCS Inc. (NASDAQ: BTCS) jumped 21.6% to $1.3871. Cognyte Software Ltd. (NASDAQ: CGNT) gained 21% to $4.14 after reporting upbeat Q4 results. SciSparc Ltd. (NASDAQ: SPRC) rose 17.2% to $0.5619. BigBear.ai Holdings, Inc. (NYSE: BBAI) gained 15% to $3.23. ReShape Lifesciences Inc. (NASDAQ: RSLS) jumped 14.5% to $3.0350. ...

The bank managed to add significant levels of low-cost deposits during March.

Bitcoin is off to a banner start in 2023, better than many expected.
Results from JPMorgan Chase and other big banks could set the tone for the rest of the first-quarter earnings season.

It's important to learn from every failure in your investing career.